XML 38 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Quarterly Financial Data
 12 Months Ended
Dec. 31, 2015
Quarterly Financial Data [Abstract]  
Quarterly Financial Data
QUARTERLY FINANCIAL DATA (unaudited)
The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2015. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.
 
 
Quarter Ended
 
 
Mar. 31,
 
Jun. 30,
 
Sept. 30,
 
Dec. 31,
 
Mar. 31,
 
Jun. 30,
 
Sept. 30,
 
Dec. 31,
 
 
2015
 
2015
 
2015
 
2015
 
2014
 
2014
 
2014
 
2014
 
 
(Unaudited, in thousands, except share and per share information)
Revenues
 
$
34,210

 
$
40,336

 
$
12,994

 
$
37,497

 
$
12,578

 
$
50,076

 
$
37,192

 
$
31,030

Operating costs and expenses:
 
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 
Cost of revenues:
 
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 
Inventor royalties
 
9,325

 
1,265

 
116

 
7,756

 
951

 
10,694

 
4,667

 
4,358

Contingent legal fees
 
4,784

 
5,512

 
1,972

 
3,901

 
1,527

 
7,077

 
7,663

 
7,296

Litigation and licensing expenses - patents
 
8,675

 
9,012

 
10,345

 
11,341

 
8,994

 
10,820

 
9,592

 
8,208

Amortization of patents
 
13,038

 
13,228

 
13,688

 
13,113

 
11,906

 
15,532

 
13,511

 
12,796

Marketing, general and administrative expenses (including non-cash stock compensation expense)
 
10,575

 
9,587

 
9,442

 
8,572

 
11,693

 
13,181

 
11,636

 
12,044

Research, consulting and other expenses - business development
 
997

 
732

 
802

 
860

 
992

 
1,003

 
1,208

 
637

Impairment of patent-related intangible assets
 
—

 
—

 
—

 
74,731

 
2,566

 
—

 
—

 
931

Impairment of goodwill
 
—

 
—

 
—

 
30,149

 
—

 
—

 
—

 
—

Other
 
426

 
—

 
3,465

 
250

 
—

 
—

 
1,548

 
—

Total operating costs and expenses
 
47,820

 
39,336

 
39,830

 
150,673

 
38,629

 
58,307

 
49,825

 
46,270

Operating income (loss)
 
(13,610
)
 
1,000

 
(26,836
)
 
(113,176
)
 
(26,051
)
 
(8,231
)
 
(12,633
)
 
(15,240
)
Total other income (expense)
 
228

 
(104
)
 
(180
)
 
—

 
109

 
(196
)
 
(57
)
 
(451
)
Income (loss) before (provision for) benefit from income taxes
 
(13,382
)
 
896

 
(27,016
)
 
(113,176
)
 
(25,942
)
 
(8,427
)
 
(12,690
)
 
(15,691
)
Benefit from (provision for) income taxes
 
(170
)
 
(119
)
 
(337
)
 
(4,174
)
 
1,372

 
(4,689
)
 
(145
)
 
(450
)
Net income (loss) including noncontrolling interests
 
(13,552
)
 
777

 
(27,353
)
 
(117,350
)
 
(24,570
)
 
(13,116
)
 
(12,835
)
 
(16,141
)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries
 
422

 
(4,463
)
 
43

 
1,440

 
149

 
167

 
420

 
(103
)
Net loss attributable to Acacia Research Corporation
 
$
(13,130
)
 
$
(3,686
)
 
$
(27,310
)
 
$
(115,910
)
 
$
(24,421
)
 
$
(12,949
)
 
$
(12,415
)
 
$
(16,244
)
Net loss per common share attributable to Acacia Research Corporation:
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Basic and diluted income (loss) per share
 
$
(0.27
)
 
$
(0.08
)
 
$
(0.55
)
 
$
(2.33
)
 
$
(0.51
)
 
$
(0.27
)
 
$
(0.26
)
 
$
(0.34
)
Weighted-average number of shares outstanding, basic and diluted
 
49,212,207

 
49,423,472

 
49,630,369

 
49,749,941

 
48,329,375

 
48,543,334

 
48,806,334

 
48,944,914